Omalizumab 150mg/1ml solution for injection pre-filled syringes
NHS hospitals in England used £47,495,589 of indicative cost of Omalizumab 150mg/1ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 3.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Omalizumab 150mg/1ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Omalizumab 150mg/1ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £3,608,385 |
| Leeds Teaching Hpls Nhs Trust | £2,888,347 |
| Manchester University Nhs Ft | £2,375,791 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,762,824 |
| Salford Royal Nhs Foundation Trust | £1,761,031 |
| Oxford University Hospitals Nhs Ft | £1,601,962 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,355,034 |
| University Hospital Southampton Nhs Ft | £1,282,543 |
| University Hospitals Plymouth Nhs Trust | £1,188,792 |
| Gloucestershire Hpls Nhs Foundation Trst | £1,086,332 |
The primary-care picture
Omalizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Omalizumab medicine page.